Orthofix stock.

Oct 11, 2022 · LEWISVILLE, Texas & CARLSBAD, Calif.--(BUSINESS WIRE)-- Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced they have entered into a definitive agreement ... Orthofix Medical Inc. (NASDAQ:OFIX) Q3 2023 Earnings Call Transcript November 8, 2023 Orthofix Medical Inc. misses on earnings expectations. Reported EPS is $-0.77471 EPS, expectations were $-0.22. Operator: Hello. Good afternoon, and welcome to the Orthofix Third Quarter Earnings Conference Call.Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the five-year results from the U.S. clinical study comparing the M6-C ™ artificial cervical disc with anterior cervical discectomy and fusion (ACDF).5 de jan. de 2023 ... SeaSpine shares also ceased trading on the Nasdaq global market this morning. Holders of SeaSpine common stock will receive 0.4163 shares of ...

Stocks United States OFIX Overview Stock Screener Earnings Calendar Sectors Nasdaq | OFIX U.S.: Nasdaq Orthofix Medical Inc. Watch list NEW Set a price target alert Open Last Updated: Nov 21,...Item 8.01 Other Events. Orthofix Medical Inc. ("Orthofix") today announced that it received an unsolicited, non-binding indication of interest from two private equity fund sponsors to acquire all of the outstanding equity of Orthofix for $23.00 per share in cash. The non-binding indication of interest was subject to, among other things, the completion …On this news, Orthofix's stock price fell $5.62 per share, or 30.17%, to close at $13.01 per share on September 12, 2023. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer …

Orthofix Medical Stock Performance OFIX stock opened at $11.12 on Monday. The company has a quick ratio of 1.13, a current ratio of 2.58 and a debt-to-equity ratio of 0.14.

This decision led to certain analysts downgrading Orthofix, causing a significant drop in the company's stock price on that day. Please visit our website to review more information and submit your ...Conference Call. Orthofix will host a conference call today at 8:30 AM Eastern time to discuss the Company's financial results for the third quarter of 2022. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. and Canada, and (240) 789-2735 in all other locations, and referencing the access code 9556380.Nov 3, 2023 · On this news, Orthofix's stock price fell $5.62 per share, or 30.17%, to close at $13.01 per share on September 12, 2023. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Fiscal Q3 2023 ended 9/30/23. Reported on 11/8/23. Get the latest Orthofix Medical Inc (OFIX) real-time quote, historical performance, charts, and other financial information to …

Orthopedic Procedures. Designed to address the most challenging orthopedic conditions of patients of all ages, our well-rounded product lines and digital services offer solutions for limb reconstruction, whether post-traumatic, correction of deformity, limb lengthening, or pediatric surgery and foot & ankle specialties. Ultimately, we help our ...

NEW YORK, NY / ACCESSWIRE / October 23, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional information and assist the investigation by …

Orthofix Medical Inc. Enters into Financing Agreement with Blue Torch Finance LLC. Nov. 08. CI. Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q3 Revenue $184M, vs. Street Est of $185.8M. Nov. 08. MT. Orthofix Medical Inc. Revises Earnings Guidance for the Year Ending December 31, 2023.3 analysts have issued 12-month price targets for Orthofix Medical's shares. Their OFIX share price targets range from $12.00 to $16.00. On average, they predict the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 22.0% from the stock's current price.06/20/2023 - 04:01 PM . LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik has been re-appointed as the Chair of the Company’s Board of Directors. Additionally, shareholders re-elected Wayne Burris who previously served on the …If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...5 de jan. de 2023 ... SeaSpine shares also ceased trading on the Nasdaq global market this morning. Holders of SeaSpine common stock will receive 0.4163 shares of ...

Jan 4, 2023 · SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock owned. Orthofix, as the corporate parent entity in the combined company structure, will continue to trade ... Nov 17, 2023 · Orthofix Medical stock has received a consensus rating of buy. The average rating score is and is based on 3 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Orthofix ... About Orthofix. Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).Orthofix Medical (NASDAQ: OFIX) is owned by 92.92% institutional shareholders, 13.59% Orthofix Medical insiders, and 0.00% retail investors. Cooper Robert Gaines is the largest individual Orthofix Medical shareholder, owning 1.53M shares representing 4.15% of the company. Cooper Robert Gaines's Orthofix Medical shares are currently valued at ...

Nov 24, 2023 · OFIX is a medical device company that provides orthopedic and spine solutions to healthcare providers. The stock has a Morningstar rating of 3 stars, a price/earnings ratio of 45.96, and a dividend yield of 0%. See the latest news, financials, valuations, and sustainability of OFIX on Morningstar.

According to the issued ratings of 3 analysts in the last year, the consensus rating for Orthofix Medical stock is Hold based on the current 3 hold ratings for OFIX. The average twelve-month price prediction for Orthofix Medical is $14.00 with a high price target of $16.00 and a low price target of $12.00. Learn more on OFIX's analyst rating ...SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common ...NEW YORK, NY / ACCESSWIRE / October 29, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional information and assist the investigation by …Conference Call. Orthofix will host a conference call today at 8:30 AM Eastern time to discuss the Company's financial results for the third quarter of 2022. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. and Canada, and (240) 789-2735 in all other locations, and referencing the access code …Exhibit 10.5 . ORTHOFIX INTERNATIONAL N.V. AMENDED AND RESTATED . STOCK PURCHASE PLAN, AS AMENDED (showing changes through Amendment No. 4) The Orthofix Inc. Employee Stock Purchase Plan is hereby amended, restated and renamed the “Orthofix International N.V. Amended and Restated Stock Purchase Plan,” and adopted by the Company, effective as of the Effective Date.NEW YORK, NY / ACCESSWIRE / October 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional information and assist the investigation by …Fiscal Q3 2023 ended 9/30/23. Reported on 11/8/23. Get the latest Orthofix Medical Inc (OFIX) real-time quote, historical performance, charts, and other financial information to …

Orthofix’s stock price dropped about 25% following its announcement, down to about $13.56. Orthofix SeaSpine CEO Chutes and Ladders executives C-suite Devices. Connect. The Team; Advertise;

Orthofix Medical Inc. (NASDAQ:NASDAQ:OFIX) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ETCompany ParticipantsAlexa Huerta - Senior Director,...

August 08, 2023 at 06:19 pm EDT. LEWISVILLE, Texas (AP) — LEWISVILLE, Texas (AP) — Orthofix Medical Inc. (OFIX) on Tuesday reported a loss of $39.4 million in its second quarter. On a per-share basis, the Lewisville, Texas -based company said it had a loss of $1.07. Earnings, adjusted for non-recurring costs and costs related to mergers and ...Nov 28, 2023 · Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate’s previously announced acquisition by Enovis Corporation (NYSE: ENOV). At that time, Mr. Calafiore is also expected to join ... Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of the WaveForm ® A interbody for Anterior Lumbar Interbody Fusion (ALIF) procedures. The WaveForm A interbody seamlessly integrates with the company’s Meridian ALIF system for treating …Real time Orthofix Medical (OFIX) stock price quote, stock graph, news & analysis. Shares of Orthofix Medical (. OFIX Quick Quote. OFIX - Free Report) have plunged 4.5% since the release of its third-quarter earnings on Nov 8. The company delivered third-quarter 2023 adjusted ...October 12, 2023 - 7:00 am. LEWISVILLE, Texas Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove ™, an advanced bioactive synthetic graft. Available in both a putty and strip configuration, OsteoCove was carefully formulated to provide ...12 de set. de 2023 ... The news caused shares of the Lewisville, TX-based company to drop nearly 27%. Ryan Zimmerman, an analyst with BTIG, commented on the board's ...Orthofix’s recent financial performance also informs the Hold rating. While the company has shown some growth, with a modest year-over-year increase in sales, it has …New York, New York--(Newsfile Corp. - November 9, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such ...Orthofix appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release ...

Story continues LEWISVILLE, Texas, November 08, 2023--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September …17 de out. de 2023 ... Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next 30-90 days. Recent stocks from this ...This decision led to certain analysts downgrading Orthofix, causing a significant drop in the company's stock price on that day. Please visit our website to review more information and submit your ...Instagram:https://instagram. metatrader 5 futures brokerschange wholesale newsland investment companiestop 10 us forex brokers Orthofix Medical has a market cap or net worth of $413.88 million as of November 29, 2023. Its market cap has increased by 23.58% in one year. ... is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding. Formula: Market Cap = Stock Price * Shares ... how much money is in a gold barnspt Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced Fitbone ™ TAA intramedullary limb-lengthening system has passed 5,000 devices implanted to date with more than 20 years of clinical history demonstrating safety and effectiveness in limb lengthening and deformity …1 day ago · Orthofix Medical Inc. has had a lackluster performance in 2023 and has brought in a new CEO to turn the company around. Read why OFIX stock is a hold. charles schwab money market account rate Had Orthofix not performed such manipulation in Q3, the stock would already be well below $30. So again, just to be clear, Orthofix's past history of Medicare and accounting fraud are not the ...LEWISVILLE, Texas, November 08, 2023--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2023. Net sales were $184.0 million, earnings per ...Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983 ...